Features
Excel add-in
PowerPoint add-in
Power BI visual
Security
Pricing
FAQ
Sign in
Sign up
Sign up
Download PNG
Download SVG
Revenue → Gross profit: DKK9.8B
Diabetes care → Revenue: DKK8.3B
GLP-1 → Diabetes care: DKK5.9B
Gross profit → Operating profit: DKK5.8B
Operating profit → Net profit: DKK4.4B
Gross profit → Operating cost: DKK4.0B
Obesity care → Revenue: DKK2.8B
Insulin → Diabetes care: DKK2.2B
Operating cost → Sales & distribution: DKK2.2B
Revenue → Cost of sales: DKK1.9B
Operating cost → R&D: DKK1.5B
Operating profit → Tax: DKK1.2B
Rare disease → Revenue: DKK0.7B
Operating profit → Financial items: DKK0.3B
Operating cost → Administrative costs: DKK0.2B
Other diabetes → Diabetes care: DKK0.1B
Operating cost → Other costs: DKK0.0B
Administrative costs
DKK0.2B
5% Y/Y
Cost of sales
DKK1.9B
30% Y/Y
Diabetes care
DKK8.3B
10% Y/Y
Financial items
DKK0.3B
2342% Y/Y
GLP-1
DKK5.9B
13% Y/Y
Gross profit
DKK9.8B
18% Y/Y
Insulin
DKK2.2B
4% Y/Y
Net profit
DKK4.4B
14% Y/Y
Obesity care
DKK2.8B
67% Y/Y
Operating cost
DKK4.0B
12% Y/Y
Operating profit
DKK5.8B
21% Y/Y
Other costs
$2.1M
Other diabetes
DKK0.1B
-19% Y/Y
R&D
DKK1.5B
20% Y/Y
Rare disease
DKK0.7B
5% Y/Y
Revenue
DKK11.7B
19% Y/Y
Sales & distribution
DKK2.2B
12% Y/Y
Tax
DKK1.2B
23% Y/Y
Novo Nordisk Q1 FY25 Income Statement
created with SankeyArt.com
2023
Full Year
2024
H1
2025
Q1
Q3
Copy and edit diagram